| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 01/29/1997 | EP0755243A1 Detergent composition |
| 01/29/1997 | EP0755222A1 Microfluidization of calcium/oxyanion-containing particles |
| 01/28/1997 | CA2113633C Liquid deodorant compositions |
| 01/23/1997 | WO1997002051A2 Cascade polymer complexes |
| 01/23/1997 | WO1997002017A1 Controlled release formulations for poorly soluble drugs |
| 01/23/1997 | WO1997002016A1 Preparations and methods for the treatment of t cell mediated diseases |
| 01/23/1997 | WO1996041634A3 Use of a non-nucleoside reverse transcriptase inhibitor in association with nucleoside inhibitors for the treatment of hiv infection |
| 01/23/1997 | CA2226008A1 Controlled release formulations for poorly soluble drugs |
| 01/23/1997 | CA2225959A1 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 01/22/1997 | EP0754445A2 Photostable cosmetic light screening compositions |
| 01/22/1997 | EP0754183A1 Novel spiro[indole-pyrrolidine] derivatives as melatoninergic agonists, method for preparing same and use thereof as a drug |
| 01/22/1997 | EP0754061A1 New oral pharmaceutical dosage form |
| 01/22/1997 | EP0536235B1 Pressurised aerosol compositions |
| 01/22/1997 | CN1141040A 6-substituted mycophenolic and derivatives with immunosuppressive activity |
| 01/22/1997 | CN1140998A Compositions which inhibit apoptosis, method of purifying the compositions and uses thereof |
| 01/22/1997 | CN1033839C Processing method for binding-inducing composition |
| 01/21/1997 | US5595745 Cosmetics; petroleum jelly and behenoyl lactylate salt |
| 01/21/1997 | US5595732 Polyethylene-protein conjugates |
| 01/21/1997 | US5595730 Lactate dehydrogenase inhibitors in cosmetic compositions |
| 01/21/1997 | CA2118133C Aminoguanidine spray drying process |
| 01/21/1997 | CA2039518C Cosmetic gel stick compositions |
| 01/21/1997 | CA1338854C Oxygenation of blood substitutes |
| 01/16/1997 | WO1997001329A1 New, stable medicinal compositions for generating propellant-free aerosols |
| 01/16/1997 | WO1996027378A3 Use of penciclovir for the treatment of human herpes-virus-8 |
| 01/15/1997 | EP0752860A1 Androstanes and pregnanes for allosteric modulation of gaba receptor |
| 01/15/1997 | EP0594770B1 Oxicam or oxicam derivatives-containing ophthalmic compositions |
| 01/15/1997 | CN1140455A Diastereomeric pure trifluoromethyl ketone peptide derivs. as inhibitors of human leukocyte elastase |
| 01/15/1997 | CN1140448A New compounds with analgesic and local anaesthetic effect |
| 01/15/1997 | CN1140165A Arylsulfonyl hydroxamic acid derivatives |
| 01/15/1997 | CN1140164A Antiarrhythmic and cardioprotective substituted indenoyiguanidines |
| 01/14/1997 | US5594031 Methods and compositions for the treatment of the skin |
| 01/09/1997 | DE19525924A1 Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel Cascade polymer complexes, process for their preparation and pharmaceutical compositions containing them |
| 01/08/1997 | CN1139917A Calcium receptor-active arylalkyl amines |
| 01/07/1997 | US5591733 Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 01/07/1997 | US5591721 Orally administering oligonucleotide with phosphorothioate internucleoside linkage |
| 01/07/1997 | US5591452 Controlled release formulation |
| 01/07/1997 | CA1338828C Bispecific antibody determinants |
| 01/02/1997 | EP0750492A1 Inhalation composition containing lactose pellets |
| 01/02/1997 | DE19625027A1 Medicament prepn. for prodn. of propellant gas-free aerosol |
| 12/31/1996 | US5589453 Viricides |
| 12/31/1996 | US5589169 Topical application of tissue plasminogen activator |
| 12/31/1996 | US5589163 Permanent wave composition and method |
| 12/27/1996 | WO1996041634A2 Use of a non-nucleoside reverse transcriptase inhibitor in association with nucleoside inhibitors for the treatment of hiv infection |
| 12/27/1996 | WO1996041614A1 Sunscreen compositions |
| 12/27/1996 | WO1996032924A3 Antiperspirant composition and manufacturing method |
| 12/27/1996 | EP0749300A1 Pharmaceutical excipient having improved compressibility |
| 12/27/1996 | EP0625190B1 New bacterium causing poultry disease and vaccine derived thereof |
| 12/25/1996 | CN1138827A Process for solubilizing difficultly soluble pharmaceutical actives |
| 12/25/1996 | CN1033640C 2-substituted-5-substituted-1, 3-oxathiolanes with antiviral properties |
| 12/24/1996 | US5587497 19-nor-vitamin D compounds |
| 12/24/1996 | US5587480 Treating hiv and hepatitis virus infections |
| 12/24/1996 | US5587363 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
| 12/24/1996 | US5587199 Suspending in aqueous phase magnetite iron oxide particles, amphipathic phosphoric acid ester, nonionic surfactant; sonicating, microfluidizing or heating to organize amphipathic compound into three-dimensional structure |
| 12/24/1996 | US5587153 Clear, gelled aluminum and zirconium salt containing antiperspirant formulation |
| 12/19/1996 | WO1996040239A1 Modified meningococcal polysaccharide conjugate vaccines |
| 12/19/1996 | WO1996040234A1 In ovo vaccination against coccidiosis |
| 12/18/1996 | EP0748227A1 Gas-containing microcapsules useful as contrast agents for diagnostic imaging |
| 12/18/1996 | CN1138298A Vaccines |
| 12/17/1996 | US5585234 Treatment of infertile sperm in vitro with thymosin α1 to enhance penetration of mammalian ova |
| 12/17/1996 | US5585103 Induction of cytotoxic T-lymphocyte responses |
| 12/17/1996 | US5585089 Humanized immunoglobulins |
| 12/12/1996 | WO1996039408A1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES |
| 12/12/1996 | WO1996039406A1 NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT |
| 12/12/1996 | WO1996039153A2 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis |
| 12/12/1996 | WO1996039147A2 Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases |
| 12/12/1996 | WO1996039119A1 Topical vehicles containing solubilized and stabilized azelaic acid |
| 12/12/1996 | WO1996039115A1 Methods and compositions for use against dental calculus in domestic animals |
| 12/12/1996 | WO1996039113A2 Oral administration of pneumococcal antigens |
| 12/12/1996 | WO1996027364A3 Anhydrous delivery vehicle for cosmetic ingredients |
| 12/12/1996 | CA2223383A1 Topical vehicles containing solubilized and stabilized azelaic acid |
| 12/12/1996 | CA2222965A1 Oral administration of pneumococcal antigens |
| 12/12/1996 | CA2222915A1 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis |
| 12/11/1996 | EP0747042A1 Compositions containing azole derivatives for topical application to skin |
| 12/11/1996 | EP0747041A2 Petroleum jelly containing cosmetic composition |
| 12/11/1996 | EP0747038A2 Thickened and stabilized cosmetic sunscreen emulsions |
| 12/11/1996 | EP0746329A1 Anti-inflammatory factor, method of isolation, and use |
| 12/11/1996 | EP0695168B1 Surfactant composition containing a sodium polyoxyethylene alkyl ether sulfate surfactant and a sulphosuccinate surfactant |
| 12/10/1996 | US5583248 Amino acid derivatives having antiviral activity |
| 12/10/1996 | US5583109 Method of stimulating immune response |
| 12/10/1996 | US5582990 Nucleotide sequence which codes antigen used for detection of lyme disease |
| 12/10/1996 | US5582832 Compositions for topical application to skin |
| 12/07/1996 | CA2173043A1 Thickened and stabilized cosmetic emulsion compositions |
| 12/05/1996 | WO1996038156A1 Use of alendronate for the prevention of osteoporosis |
| 12/05/1996 | WO1996038154A1 Means for treating radiation injuries |
| 12/05/1996 | WO1996038151A1 Method for treating cognitive dysfunction |
| 12/05/1996 | CA2222539A1 Agent for the treatment of radiation injuries |
| 12/05/1996 | CA2222318A1 Use of alendronate for the prevention of osteoporosis |
| 12/04/1996 | EP0745075A1 6-substituted mycophenolic and derivatives with immunosuppressive activity |
| 12/04/1996 | EP0630230B1 Pharmaceutical inhalation compositions |
| 12/04/1996 | EP0479920B1 Novel antibodies reactive with human carcinomas |
| 12/04/1996 | CN1137037A Quinazoline derivatives |
| 12/03/1996 | US5580855 Analgesics |
| 11/28/1996 | WO1996037199A1 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof |
| 11/28/1996 | WO1996037190A1 Stable, concentrated, locally-tolerated erythromycylamine solutions |
| 11/28/1996 | WO1996037186A1 Clear cosmetic stick composition |
| 11/28/1996 | WO1996037185A1 Clear cosmetic stick composition |
| 11/28/1996 | DE19518917A1 Stabile, konzentrierte lokalverträgliche Erythromycylamin-Lösungen Stable, concentrated locally acceptable solutions erythromycylamine |
| 11/28/1996 | CA2221794A1 Clear cosmetic stick composition |
| 11/28/1996 | CA2221777A1 Clear cosmetic stick composition |
| 11/28/1996 | CA2221458A1 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof |